Posted in | News | Control Systems

Insitu Releases ICOMC2 2.0 Small-Footprint Common Command and Control System

Insitu announced today the 2.0 release of ICOMC2, the company's innovative, small-footprint common command and control system. Since its introduction in 2012, ICOMC2 has redefined the Unmanned Aircraft System control concept. It enables a single operator to control multiple unmanned vehicles using small-footprint, mobile hardware and features an open-architecture design that users can customize with plug-ins and new applications.

ICOMC2 2.0 includes a mission commander mode, which increases situational awareness and integrates with other C4ISR systems, enabling ICOMC2 to provide or receive tasking between Intelligence, Surveillance and Reconnaissance systems.

ICOMC2 2.0 features a high-performance, lightweight mapping engine, a full-featured Software Development Kit, lower memory footprint for mobile usage, and new video formats.

"ICOMC2 2.0 represents how Insitu is leading the way with small-footprint technology that is flexible and scalable," said Ryan Hartman, senior vice president, Insitu programs. "This technology signifies a quantum leap for customers by providing a UAS system that can task, process, exploit and disseminate information and effects to end users."

Through the ICOMC2 Registered Developers Program, third parties receive support developing plug-ins for the system's core. The program also supports the University Partnerships Program, a cost-effective solution for colleges and universities that want to offer courses or degrees in unmanned technology.

Insitu Inc., located in Bingen, Wash., is a wholly owned subsidiary of The Boeing Company. Insitu designs, develops and manufactures UAS and provides associated services for commercial, civil and defense applications. To date, our systems have accumulated more than 768,000 operational flight hours and 94,000 sorties in support of global missions. For more information, visit www.insitu.com.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.